Six new innovations with potential to benefit society will receive university funding to aid in the transition from early-stage research into real-world products and services. Two of the six projects awarded in 2022 are to faculty in the Department of Molecular Biology.
In a paper published Feb. 28 in the journal eLife, a team of researchers headed by Alexander Ploss settle a debate about a key protein in hepatitis E (Hep E), which could open the way to developing treatments for a tiny virus that poses an outsized threat to public health around the globe.
